Velizar Shivarov

15.9k total citations
47 papers, 372 citations indexed

About

Velizar Shivarov is a scholar working on Immunology, Hematology and Genetics. According to data from OpenAlex, Velizar Shivarov has authored 47 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 16 papers in Hematology and 13 papers in Genetics. Recurrent topics in Velizar Shivarov's work include Acute Myeloid Leukemia Research (12 papers), T-cell and B-cell Immunology (9 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers). Velizar Shivarov is often cited by papers focused on Acute Myeloid Leukemia Research (12 papers), T-cell and B-cell Immunology (9 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers). Velizar Shivarov collaborates with scholars based in Bulgaria, United States and United Kingdom. Velizar Shivarov's co-authors include Milena Ivanova, Ramón V. Tiu, Ralitza Gueorguieva, Lars Bullinger, Tasuku Honjo, Reiko Shinkura, Xiwen Gu, Matthew P. Strout, Lazar Jelev and L. Surchev and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Velizar Shivarov

44 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Velizar Shivarov Bulgaria 11 161 127 93 90 49 47 372
Ruxiu Tie China 11 131 0.8× 100 0.8× 103 1.1× 45 0.5× 47 1.0× 19 381
Siham Boukour France 10 174 1.1× 245 1.9× 102 1.1× 96 1.1× 78 1.6× 11 495
Seiichiro Katagiri Japan 14 199 1.2× 207 1.6× 65 0.7× 116 1.3× 50 1.0× 59 498
Anja Troeger Germany 12 183 1.1× 91 0.7× 170 1.8× 104 1.2× 30 0.6× 35 493
Keiko Kagami Japan 11 130 0.8× 129 1.0× 78 0.8× 61 0.7× 30 0.6× 37 379
Bhumi Patel United States 7 150 0.9× 105 0.8× 80 0.9× 36 0.4× 23 0.5× 9 378
Nahoko Nishimoto Japan 10 216 1.3× 296 2.3× 54 0.6× 76 0.8× 60 1.2× 13 476
Michael Svatoň Czechia 11 84 0.5× 52 0.4× 139 1.5× 71 0.8× 25 0.5× 23 315
Árpád Bátai Hungary 13 138 0.9× 253 2.0× 71 0.8× 152 1.7× 20 0.4× 32 386
Daiki Karigane Japan 10 128 0.8× 140 1.1× 80 0.9× 54 0.6× 33 0.7× 31 337

Countries citing papers authored by Velizar Shivarov

Since Specialization
Citations

This map shows the geographic impact of Velizar Shivarov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Velizar Shivarov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Velizar Shivarov more than expected).

Fields of papers citing papers by Velizar Shivarov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Velizar Shivarov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Velizar Shivarov. The network helps show where Velizar Shivarov may publish in the future.

Co-authorship network of co-authors of Velizar Shivarov

This figure shows the co-authorship network connecting the top 25 collaborators of Velizar Shivarov. A scholar is included among the top collaborators of Velizar Shivarov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Velizar Shivarov. Velizar Shivarov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shivarov, Velizar, et al.. (2025). A Concise Review of the Role of the NKG2D Receptor and Its Ligands in Cancer. SHILAP Revista de lepidopterología. 5(1). 9–9. 5 indexed citations
2.
Shivarov, Velizar & Milena Ivanova. (2024). Characterisation of novel MICB alleles by next generation sequencing: MICB*055 and MICB*005:15. HLA. 103(6). e15581–e15581. 2 indexed citations
3.
Yordanov, Angel, et al.. (2024). Integrated Analysis of Phagocytic and Immunomodulatory Markers in Cervical Cancer Reveals Constellations of Potential Prognostic Relevance. International Journal of Molecular Sciences. 25(16). 9117–9117.
4.
Metodiev, Metodi V., et al.. (2024). Utility of expression of 4-hydroxynonenal tested by immunohistochemistry for cervical cancer. Menopausal Review. 23(1). 6–13. 3 indexed citations
5.
Shivarov, Velizar, et al.. (2023). Relative Risk of Death in Bulgarian Cancer Patients during the Initial Waves of the COVID-19 Pandemic. Healthcare. 11(18). 2594–2594. 1 indexed citations
6.
Ivanova, Milena, et al.. (2023). Possible impact of HLA class I and class II on malignancies driven by a single germ‐line BRCA1 mutation. International Journal of Immunogenetics. 50(5). 243–248. 1 indexed citations
7.
Ivanova, Milena, et al.. (2023). Exploration of the role of NKG2D ligands MICA and MICB in JAK2 V617F‐positive myeloproliferative neoplasms. HLA. 102(2). 168–178. 1 indexed citations
8.
Shivarov, Velizar, et al.. (2023). Infiltration by Intratumor and Stromal CD8 and CD68 in Cervical Cancer. Medicina. 59(4). 728–728. 2 indexed citations
9.
Shivarov, Velizar, et al.. (2023). A Novel Two-Gene Expression-Based Prognostic Score in Malignant Pleural Mesothelioma. Diagnostics. 13(9). 1556–1556. 1 indexed citations
10.
Shivarov, Velizar, et al.. (2023). Seasonal Pattern of Cerebrovascular Fatalities in Cancer Patients. Healthcare. 11(4). 456–456. 3 indexed citations
11.
Shivarov, Velizar, et al.. (2023). Reactivity Graph Yields Interpretable IgM Repertoire Signatures as Potential Tumor Biomarkers. International Journal of Molecular Sciences. 24(3). 2597–2597. 2 indexed citations
12.
Shivarov, Velizar, et al.. (2023). The relevance of HLA class II genes in JAK2 V617F-positive myeloproliferative neoplasms. Human Immunology. 84(3). 199–207.
13.
Shivarov, Velizar, et al.. (2022). Seasonality of Deaths Due to Heart Diseases among Cancer Patients. Medicina. 58(11). 1651–1651. 2 indexed citations
14.
Yordanov, Angel, et al.. (2022). Prognostic Utility of CD47 in Cancer of the Uterine Cervix and the Sensitivity of Immunohistochemical Scores. Diagnostics. 13(1). 52–52. 7 indexed citations
15.
Savov, Alexey, et al.. (2022). Restriction of the Global IgM Repertoire in Antiphospholipid Syndrome. Frontiers in Immunology. 13. 865232–865232. 2 indexed citations
16.
17.
Shivarov, Velizar, et al.. (2021). Bringing Together the Power of T Cell Receptor Mimic and Bispecific Antibodies for Cancer Immunotherapy: Still a Long Way to Go. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 40(2). 81–85. 1 indexed citations
18.
Ivanova, Milena, et al.. (2020). Probable HLA-mediated immunoediting of JAK2 V617F-driven oncogenesis. Experimental Hematology. 92. 75–88.e10. 5 indexed citations
19.
Shivarov, Velizar, et al.. (2016). EPAS1 p.M535T mutation in a Bulgarian family with congenital erythrocytosis. Hematology. 21(10). 619–622. 7 indexed citations
20.
Shivarov, Velizar, Ivaylo Christov, Plamena R. Angelova, et al.. (2011). Amplification of c-MYC and MLL Genes as a Marker of Clonal Cell Progression in Patients with Myeloid Malignancy and Trisomy of Chromosomes 8 or 11. SHILAP Revista de lepidopterología. 14(2). 17–24. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruxiu Tie Breakdown of academic impact, for papers by Siham Boukour Breakdown of academic impact, for papers by Seiichiro Katagiri Breakdown of academic impact, for papers by Anja Troeger Breakdown of academic impact, for papers by Keiko Kagami Breakdown of academic impact, for papers by Bhumi Patel Breakdown of academic impact, for papers by Nahoko Nishimoto Breakdown of academic impact, for papers by Michael Svatoň Breakdown of academic impact, for papers by Árpád Bátai Breakdown of academic impact, for papers by Daiki Karigane
Rankless by CCL
2026